Search Results
Atezolizumab in metastatic TNBC: Long-term clinical outcomes and biomarker analyses
ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
IMpassion130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC
IMpassion130: results of atezolizumab plus nab-paclitaxel for frontline TNBC
Dr. Kalinsky on Clinical Impact of Atezolizumab Combo in TNBC
Triple Negative Breast Cancer: Predictive and Prognostic Biomarkers for Neo/Adjuvant Therapy
IMPassion130: atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naiv...
PD-L1 and TMB as biomarkers in the IMvigor211 trial of atezolizumab vs. chemo for bladder cancer
Neelima Denduluri, MD -- Treatment of Triple Negative Breast Cancer
Dr. Hamilton on FDA Approval of Atezolizumab/Nab-Paclitaxel in TNBC
Dr. Nanda on Immunotherapy in Metastatic TNBC
